Publication:
Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis.

dc.contributor.authorPrieto-Peña, Diana
dc.contributor.authorRemuzgo-Martinez, Sara
dc.contributor.authorGenre, Fernanda
dc.contributor.authorPulito-Cueto, Veronica
dc.contributor.authorAtienza-Mateo, Belen
dc.contributor.authorLlorca, Javier
dc.contributor.authorSevilla-Perez, Belen
dc.contributor.authorOrtego-Centeno, Norberto
dc.contributor.authorMarquez, Ana
dc.contributor.authorLera-Gomez, Leticia
dc.contributor.authorLeonardo, Maria Teresa
dc.contributor.authorPeñalba, Ana
dc.contributor.authorNarvaez, Javier
dc.contributor.authorMartin-Penagos, Luis
dc.contributor.authorRodrigo, Emilio
dc.contributor.authorMiranda-Filloy, Jose A
dc.contributor.authorCaminal-Montero, Luis
dc.contributor.authorCollado, Paz
dc.contributor.authorSanchez Perez, Javier
dc.contributor.authorde Argila, Diego
dc.contributor.authorRubio, Esteban
dc.contributor.authorLeon Luque, Manuel
dc.contributor.authorBlanco-Madrigal, Juan Maria
dc.contributor.authorGalindez-Agirregoikoa, Eva
dc.contributor.authorGualillo, Oreste
dc.contributor.authorMartin, Javier
dc.contributor.authorCastañeda, Santos
dc.contributor.authorBlanco, Ricardo
dc.contributor.authorGonzalez-Gay, Miguel A
dc.contributor.authorLopez-Mejias, Raquel
dc.contributor.funderEuropean Union FEDER funds
dc.contributor.funderInstituto de Salud Carlos III’ (ISCIII, Health Ministry, Spain)
dc.date.accessioned2023-02-09T11:46:21Z
dc.date.available2023-02-09T11:46:21Z
dc.date.issued2021-07-30
dc.description.abstractCytokines signalling pathway genes are crucial factors of the genetic network underlying the pathogenesis of Immunoglobulin-A vasculitis (IgAV), an inflammatory vascular condition. An influence of the interleukin (IL)33- IL1 receptor like (IL1RL)1 signalling pathway on the increased risk of several immune-mediated diseases has been described. Accordingly, we assessed whether the IL33-IL1RL1 pathway represents a novel genetic risk factor for IgAV. Three tag polymorphisms within IL33 (rs3939286, rs7025417 and rs7044343) and three within IL1RL1 (rs2310173, rs13015714 and rs2058660), that also were previously associated with several inflammatory diseases, were genotyped in 380 Caucasian IgAV patients and 845 matched healthy controls. No genotypes or alleles differences were observed between IgAV patients and controls when IL33 and IL1RL1 variants were analysed independently. Likewise, no statistically significant differences were found in IL33 or IL1RL1 genotype and allele frequencies when IgAV patients were stratified according to the age at disease onset or to the presence/absence of gastrointestinal (GI) or renal manifestations. Similar results were disclosed when IL33 and IL1RL1 haplotypes were compared between IgAV patients and controls and between IgAV patients stratified according to the clinical characteristics mentioned above. Our results suggest that the IL33-IL1RL1 signalling pathway does not contribute to the genetic network underlying IgAV.
dc.description.sponsorshipWe are indebted to the patients and healthy controls for their essential collaboration to this study. We also thank the National DNA Bank Repository (Salamanca) for supplying part of the control samples. This study was supported by European Union FEDER funds and `Fondo de Investigaciones Sanitarias´ (Grant PI18/00042) from ‘Instituto de Salud Carlos III’ (ISCIII, Health Ministry, Spain). DP-P is a recipient of a Río Hortega programme fellowship from the ISCIII, co-funded by the European Social Fund (ESF, `Investing in your future´) (Grant Number CM20/00006). SR-M is supported by funds of the RETICS Program (RD16/0012/0009) (ISCIII, co-funded by the European Regional Development Fund (ERDF)). VP-C is supported by a pre-doctoral grant from IDIVAL (PREVAL 18/01). BA-M is a recipient of a `López Albo´ Post-Residency Programme funded by Servicio Cántabro de Salud. LL-G is supported by funds from IDIVAL (INNVAL20/06). OG is staff personnel of Xunta de Galicia (Servizo Galego de Saude (SERGAS)) through a research-staff stabilization contract (ISCIII/SERGAS) and his work is funded by ISCIII and the European Union FEDER fund (Grant Numbers RD16/0012/0014 (RIER) and PI17/00409). He is beneficiary of project funds from the Research Executive Agency (REA) of the European Union in the framework of MSCA-RISE Action of the H2020 Programme, project 734899—Olive-Net. RL-M is a recipient of a Miguel Servet type I programme fellowship from the ISCIII, co-funded by ESF (`Investing in your future´) (Grant Number CP16/00033).
dc.description.versionSi
dc.identifier.citationPrieto-Peña D, Remuzgo-Martínez S, Genre F, Pulito-Cueto V, Atienza-Mateo B, Llorca J, et al. Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis. Sci Rep. 2021 Aug 9;11(1):16163.
dc.identifier.doi10.1038/s41598-021-95762-5
dc.identifier.essn2045-2322
dc.identifier.pmcPMC8352942
dc.identifier.pmid34373564
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352942/pdf
dc.identifier.unpaywallURLhttps://www.nature.com/articles/s41598-021-95762-5.pdf
dc.identifier.urihttp://hdl.handle.net/10668/18352
dc.issue.number1
dc.journal.titleScientific reports
dc.journal.titleabbreviationSci Rep
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number8
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.projectIDPI18/00042
dc.relation.projectIDRD16/0012/0009
dc.relation.projectIDRD16/0012/0014
dc.relation.projectIDPI17/00409
dc.relation.projectIDCP16/00033
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectGene Regulatory Networks
dc.subjectGene Frequency
dc.subjectAdolescent
dc.subjectCase-Control Studies
dc.subjectChild
dc.subjectFemale
dc.subject.decsAdulto Joven
dc.subject.decsGenotipo
dc.subject.decsHaplotipos
dc.subject.decsInmunoglobulina A
dc.subject.decsInterleucina-33
dc.subject.decsPolimorfismo de nucleótido
dc.subject.decsPredisposición genética a la enfermedad
dc.subject.decsProteína 1 similar al receptor de interleucina-1
dc.subject.decsVasculitis por IgA
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshGenotype
dc.subject.meshHaplotypes
dc.subject.meshHumans
dc.subject.meshIgA Vasculitis
dc.subject.meshImmunoglobulin A
dc.subject.meshInterleukin-1 Receptor-Like 1 Protein
dc.subject.meshInterleukin-33
dc.subject.meshMale
dc.subject.meshPolymorphism, Single Nucleotide
dc.subject.meshSignal Transduction
dc.subject.meshYoung Adult
dc.titleRole of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC8352942.pdf
Size:
838.93 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Prieto_Role_MaterialSuplementario.doc
Size:
65.5 KB
Format:
Microsoft Word